Raising Fibromyalgia Awareness: Here’s to a Proper Diagnosis

Obtaining a timely and accurate diagnosis of this complex, chronic pain disorder can be difficult. Knowing what to expect at the doctor’s office may ease the process. Plus: A new blood test offers hope. As we head into National Fibromyalgia Awareness day – May 12 – Practical Pain Management spoke with Dr. David A. McLain, READ MORE

New Fibromyalgia Blood Test Boasts 94 Percent Accuracy

iQuity, a Nashville-based data science company, is now offering a blood test to aid in the diagnosis of fibromyalgia. The IsolateFibromyalgia test relies on RNA gene expression to identify fibromyalgia, a disorder of unknown origin that causes body-wide pain, fatigue, cognitive issues and other debilitating symptoms. “RNA analysis is a cutting-edge tool for doctors that has great READ MORE

RNA Blood Test to Detect Fibromyalgia Introduced

IQuity releases diagnostic for the chronic musculoskeletal pain syndrome   Nashville-based data science company IQuity has unveiled a groundbreaking new blood test that uses RNA analysis to help practitioners detect fibromyalgia in patients with 94% accuracy, according to a company release.1 Called IsolateFibromyalgia, the test results can be delivered back to the healthcare practitioner within one READ MORE
IQuity Developed RNA via Medical Research

RNA-based Blood Test Can Detect Fibromyalgia

MedicalResearch.com interview with: Dr. Chase Spurlock Dr. Chase Spurlock, PhD CEO, IQuity, Specialty Diagnostic Technologies Faculty, Vanderbilt University Medical Center Dr. Spurlock discusses IQuity’s release of IsolateFibromyalgia, the first RNA-based blood test to detect fibromyalgia. MedicalResearch.com: What is the background for this test? Would you briefly explain what fibromyalgia is, whom it affects and why it has been difficult READ MORE

New Blood Test Launched for Fibromyalgia

A Tennessee laboratory has launched an innovative new blood test that uses RNA analysis to diagnose patients with fibromyalgia. IQuityLabs says its test – called IsolateFibromyalgia – can identify fibromyalgia within a week and with over 90 percent accuracy. The test costs $599. Ribonucleic acid (RNA) is a molecule that plays an essential role in sensing and communicating responses to READ MORE

Biomarkers Available to Speed Diagnosis of Fibromyalgia

quity (Nashville, Tennessee) has announced the release of IsolateFibromyalgia, an RNA analysis of blood samples, for the fast and accurate detection of fibromyalgia syndrome. IsolateFibromyalgia shows, with 94% accuracy, whether a patient’s gene expression pattern is consistent with fibromyalgia and can be ordered from IQuityLabs.com. Results are returned within 7 days of receiving a patient’s blood READ MORE
Nashville Post Press Hit for IQuity

IQuity releases blood test targeting fibromyalgia

Nashville-based data science company IQuity has announced the release of IsolateFibromyalgia, a blood test that uses RNA analysis to help health care providers accurately and quickly detect fibromyalgia syndrome. According to a release, IsolateFibromyalgia uses a simple blood draw to detect, with 94 percent accuracy, if a patient’s gene expression pattern is consistent with fibromyalgia READ MORE

IQuity launches pioneering RNA-based blood test to diagnose fibromyalgia

Groundbreaking test identifies gene expression pattern consistent with fibromyalgia syndrome, providing information that can speed pace of diagnosis Nashville-based data science company IQuity has announced the release of IsolateFibromyalgia™, a pioneering blood test that uses RNA analysis to help health care providers accurately and quickly detect fibromyalgia syndrome. IsolateFibromyalgia uses a simple blood draw to detect, with 94 READ MORE

RNA blood test for fibromyalgia launched

Data science company IQuity has announced the launch of a new blood test called IsolateFibromyalgia, which uses RNA gene expression analysis to diagnose fibromyalgia, according to a press release. “RNA analysis is a cutting-edge tool for doctors that has great potential in the field of medical diagnostics,” Chase Spurlock, PhD, CEO of IQuity, said in the release. READ MORE